Gemcitabine-loaded smart carbon nanotubes for effective targeting to cancer cells

Journal of Drug Targeting

Volumn 21, Issue 6, 2013, Pages 581-592

  Singh, Ravendra ^a   Mehra, Neelesh Kumar ^a   Jain, Vikas ^a   Jain, Narendra Kumar ^a  

^a DR H S GOUR UNIVERSITY   (India)

Author keywords

Carbon nanotubes; Folic acid; Functionalization; Gemcitabine hydrochloride; Human breast cancer cells; Pharmacokinetics

Indexed keywords

FOLIC ACID; GEMCITABINE; MULTI WALLED NANOTUBE; NANOCARRIER;

ACYLATION; AMIDATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CARBOXYLATION; CELL PH; CELL STRAIN MCF 7; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG CONJUGATION; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; ELECTRON MICROSCOPY; HEMOLYSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INFRARED SPECTROSCOPY; LYSOSOME; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; RAT; SUSTAINED DRUG RELEASE; TARGET CELL; TIME TO MAXIMUM PLASMA CONCENTRATION; X RAY DIFFRACTION;

CELL LINE, TUMOR; CHEMISTRY, PHARMACEUTICAL; DEOXYCYTIDINE; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; FOLIC ACID; HUMANS; MCF-7 CELLS; NANOTUBES, CARBON; NEOPLASMS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; X-RAY DIFFRACTION;

EID: 84879759751     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.3109/1061186X.2013.778264     Document Type: Article

References (48)

1. World Health Organization, fact sheet. Available from: http://www.who.int/cancer/en/[last accessed 3 March 2013].
2. Gupta U, Dwivedi SKD, Bid HK, et al. Ligand anchored dendrimers based nanoconstructs for effective targeting to cancer cells. Int J Pharm 2010;393:185-96.
3. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature 2009;407:249-57.
4. Tekade RK, Dutta T, Tyagi A, et al. Surface-engineered dendrimers for dual drug delivery: a receptor up-regulation and enhanced cancer targeting strategy. J Drug Target 2008;16:758-72.
5. Dubey V, Mishra D, Nahar M, et al. Enhanced transdermal delivery of an anti-HIV agent via ethanolic liposomes. Nanomed Nanotech Biol Med 2010;6:590-6.
6. Gajbhiye V, Jain NK. The treatment of glioblastoma xenografts by surfactant conjugated dendritic nanoconjugates. Biomaterials 2011; 32:6213-25.
7. Nahar M, Mishra D, Dubey V, Jain NK. Development, characterization, and toxicity evaluation of amphotericin B-loaded gelatin nanoparticles. Nanomed Nanotech Biol Med 2008;4:252-61.
8. Jain NK, Mishra V, Mehra NK. Targeted drug delivery to macrophages. Exp Opinion Drug Deliv 2013;10:353-67.
9. Mehra NK, Jain AK, Lodhi N, et al. Challenges in the use of carbon nanotubes in biomedical applications. Crit Rev Ther Drug Carr Sys 2008;25:169-220.
10. Kayat J, Gajbhiye V, Tekade RK, Jain NK. Pulmonary toxicity of carbon nanotubes. Nanomed Nanotech Biol Med 2010;7:40-9.
11. Lodhi N, Mehra NK, Jain NK. Development and characterization of dexamethasone mesylate anchored on multi walled carbon nanotubes. J Drug Target 2013;21:67-76.
12. Pruthi J, Mehra NK, Jain NK. \Macrophages targeting of amphotericin B through mannosylated multi walled carbon nanotubes. J Drug Target 2012;20:593-604.
13. Ren J, Shen S, Wang D, et al. The targeted delivery of anticancer drugs to brain glioma by PEGylated oxidised multi-walled carbon nanotubes modified with angiopep-2. Biomaterials 2012;33: 3324-33.
14. Shen S, Ren J, Chen J, et al. Development of magnetic multi walled carbon nanotubes combined with near-infrared radiation-assisted desorption for the determination of tissue distribution of doxorubicin liposome injects in rats. J Chromatography A 2011;1218: 4619-26.
15. Lu YJ, Wei KC, Ma CCM, et al. Dual targeted delivery of doxorubicin to cancer cells using folate-conjugated magnetic multiwalled carbon nanotubes. Colloids Surf B Biointerfaces 2012; 89:1-9.
16. Ji Z, Lin G, Lu Q, et al. Targeted therapy of SMMC-7721 liver cancer in vitro and in vivo with carbon nanotubes based drug delivery system. J Colloid Interface Sci 2012;365:143-9.
17. Iijima S. Helical microtubules of graphite carbon. Nature 1991;354: 56-8.
18. Mehra NK, Mishra V, Jain NK. Receptor based targeting of therapeutics. Ther Deliv 2013;4:369-94.
19. Meng L, Zhang X, Lu Q, et al. Single walled carbon nanotubes as drug delivery vehicles: targeting doxorubicin to tumors. Biomaterials 2012;33:1689-98.
20. Allen BL, Kichambare PD, Gou P, et al. Biodegradation of singlewalled carbon nanotubes through enzymatic catalysis. Nano Lett 2008;8:3899-903.
21. Bianco A, Kostarelos K, Prato M. Making carbon nanotubes biocompatible and biodegradable. Chem Commun 2011;47: 10182-8.
22. Jain AK, Mehra NK, Lodhi N, et al. Carbon nanotubes and their toxicity. Nanotoxicol 2007;1:167-97.
23. Taghdisi SM, Lavaee P, Ramezani M, Abnous K. Reversible targeting and controlled release delivery of daunorubicin to cancer cells by aptamer-wrapped carbon nanotubes. Euro J Pharm Biopharm 2011;77:200-6.
24. Zhang X, Meng L, Lu Q, et al. Targeted delivery and controlled release of doxorubicin to cancer cells using modified single wall carbon nanotubes. Biomaterials 2009;30:6041-7.
25. Lay CL, Liu HQ, Tan HR, Liu Y. Delivery of paclitaxel by physically loading onto poly(ethylene glycol) (PEG)-graft-carbon nanotubes for potent cancer therapeutics. Nanotechnol 2010; 21:065101.
26. Liu Z, Chen K, Davis C, et al. Drug delivery with carbon nanotubes for in vivo cancer treatment. Cancer Res 2008;68:6652-60.
27. Liu Z, Davis C, Cai W, et al. Circulation and long-term fate of functionalized biocompatible single-walled carbon nanotubes in mice probed by raman spectroscopy. Proc Nat Acad Sci 2008;105: 1410-15.
28. Wu W, Wieckowski S, Pastorin G, et al. Targeted delivery of Amphotericin B to cells by using functionalized carbon nanotubes. Angew Chem Int Ed Engl 2005;44:6358-62.
29. Stella B, Arpicco S, Rocco F, et al. Encapsulation of gemcitabine lipophilic derivatives into polycyanoacrylate nanospheres and nanocapsules. Int J Pharm 2007;344:71-7.
30. Vandana M, Sahoo SK. Long circulation and cytotoxicity of PEGylated gemcitabine and its potential for the treatment of pancreatic cancer. Biomaterials 2010;34:9340-56.
31. Arsawang U, Saengsawang O, Rungrotmongkoi T, et al. How do carbon nanotubes serve as carriers for gemcitabine transport in a drug delivery system? J Mol Graph Modeling 2011;29:591-6.
32. Wang S, Low PS. Folate-mediated targeting of antineoplastic drugs, imaging agents, and nucleic acids to cancer cells. J Control Rel 1998;53:39-48.
33. Singh P, Gupta U, Asthana A, Jain NK. Folate and folate-PEGPAMAM dendrimers: synthesis, characterization and targeted anticancer drug delivery potential in tumor bearing mice. Bioconj Chem 2008;19:2239-52.
34. Li J, Zhang Y. Cutting of multi walled carbon nanotubes. Appl Surf Sci 2006;252:2944-8.
35. Jain AK, Dubey V, Mehra NK, et al. Carbohydrate conjugated multi walled carbon nanotubes: development and characterization. Nanomed Nanotech Biol Med 2009;5:432-42.
36. Mishra V, Gupta U, Jain NK. Influence of different generations of poly(propylene imine) dendrimers on human erythrocytes. Pharmazie 2010;65:891-5.
37. Yoo HS, Okano T, Kataoka K, Kwon G. Polymeric micelles for solubilization and heamolytic activity of Amphotericin B. J Control Rel 1998;53:131-6.
38. Denirot F, Lang R. Rapid colorimetric assay for cell growth and survival: modification to tetrazolium dye, procedure giving improved sensitivity and reliability. Immuno Method 1986;89: 271-7.
39. Jeffery ME, Linda A, Armstrong A, Martinez S. A rapid and simple MTT based spectrophotometric assay for determining drug sensitivity in monolayer culture. Tissue Cult Method 1998;11:15-17.
40. Yoo HS, Park TG. Folate-receptor-targeted delivery of doxorubicin nano-aggregates stabilized by doxorubicin-PEG-folate conjugated. J Control Rel 2004;100:247-56.
41. Pasut G, Canal F, Via LD, et al. Antitumoral activity of PEGgemcitabine prodrugs targeted by folic acid. J Control Rel 2008; 127:239-48.
42. Cavallaro G, Mariano L, Salmaso S, et al. Folate-mediated targeting of polymeric conjugates of gemcitabine. Int J Pharm 2009;307:258-69.
43. Lee HB, Blaufox MD. Blood volume in rat. J Nucl Med 1985; 26:72-6.
44. Yudianti R, Onggo H, Sudiraman Y, et al. Analysis of functional group sited on multi-wall carbon nanotubes. The open Mat Sci 2011;5:242-7.
45. Xiang G, Wu J, Lu Y, et al. Synthesis and evaluation of a novel ligand for folate-mediated targeting liposomes. Int J Pharm 2008; 1:29-36.
46. Turk MJ, Waters DJ, Low PS. Design and regioselective synthesis of a new generation of targeted therapeutics. Canc Lett 2004; 213:165-72.
47. Singh R, Pantarotto D, Lacerda L, et al. Tissue biodistribution and blood clearance rates of intravenously administered carbon nanotubes radiotracers. Proc Nat Acad Sci 2006;103:3357-62.
48. Cherukari P, Gannon CJ, Leeuw TK, et al. Mammalian pharmacokinetics of carbon nanotubes using intrinsic near-infrared fluorescence. Proc Nat Acad Sci 2006;103:18882-6.